Need a mesothelioma lawyer? We will fight for you!
› $4.85 Billion settlement in drug case
Chantix has to be one of the most bipolar prescription drugs ever created. Every day, a search for the latest Chantix news digs up blogs written by fans of the smoking cessation drug, who often tout it as a miracle or a blessing in their struggle to become nonsmokers. Yet other users liken it to a nightmare or a curse, citing wild mood swings, disturbing dreams, and uncharacteristic thoughts of suicide.
In September, we learned that those long Chantix ads featuring the tortoise and the hare were reappearing on TV after Pfizer yanked them from the airwaves for several months. The drug maker pulled the ads when it became evident that a link existed between Chantix, depression, and suicide. Unfortunately, the new ads were even longer than the original by 30 seconds — for a total of 90 seconds — to accommodate all the new warnings.
Researchers conducting long term studies of smoking and cancer are impressed by the latest statistics, which show cancer rates falling among both men and women for the first time since the government started keeping track of long-term trends. The favorable data is especially impressive, given the country’s aging population and considering that the number of new lung cancer cases in both sexes grew by nearly one percent each year from 1995 to 1999.
An investigative report aired by the British Broadcasting Company (BBC) tells the stories of two people who became suicidal after taking Chantix (marketed by Pfizer as Champix in Europe and the UK).
Chantix became available in the UK in December of 2006. Since then, nearly 400,000 prescriptions for the drug have been written.
![[ Beasley Allen Law Firm Logo ]](http://www.chantix-legal.com/wp-content/themes/system-unity/images/logo.png){kind=logo}